Accomplishments and Controversies in Cancer Prevention and Control

Program: Plenary
Session: L7-1-Accomplishments and Controversies in Cancer Prevention and Control
Clinical
Supported by Genzyme, a Sanofi company
Tuesday, June 18, 2013: 11:25 AM-11:50 AM
Presentation Start Time: 11:25 AM
Hall D (Moscone Center)
Otis Webb Brawley*
Winship Cancer Institute, Atlanta, GA
Talk Description:

There has been significant progress in the "war on cancer." Indeed there has been a 20% decrease in age adjusted mortality over the past twenty years. Despite this there is still significant controversy about the usefulness of certain screening technologies especially for thyroid, breast and prostate cancer. There are also concerns regarding the effectiveness of certain treatments and prevention technologies.